Nitrogen dioxide as a by-product of inhaled nitric monoxide therapy. Concentration in the inhaled gas mixture acceptable in clinical practice. A systematic review

Автор: Bautin A.E., Chomakhashvili I.G., Afanasyeva K.Yu., Marichev A.O., Radovskiy A.M., Kozyrev D.A., Barygin E.K., Ablesimov G.N., Badalyan N.V., Zhuravleva M.S., Pozhidaeva A.M., Burov A.A., Valueva Yu.V.

Журнал: Патология кровообращения и кардиохирургия @journal-meshalkin

Рубрика: Обзоры

Статья в выпуске: 1 т.29, 2025 года.

Бесплатный доступ

Objective: The study aimed to review the literature data on the recommended maximum concentrations of nitrogen dioxide during inhaled therapy with nitric oxide and to propose a general list of recommendations on safe therapy with inhaled nitric oxide. Methods: The systematic review was performed according to the PRISMA 2020 criteria. A search was carried out in databases Russian Science Citation Index, MedLine, Cochrane Library using the keywords “nitrogen dioxide”, “limit concentration”, “annual limit value”, “inhaled nitric oxide”. Results: The review included 28 articles, 20 sources from regulatory authorities setting hygiene standards, and 2 instructions for devices. Conclusion: For short periods of NO inhalation not exceeding one hour, the maximum permissible concentration of NO2 in the inhaled gas mixture may be defined as 5 ppm. In cases of NO inhalation not exceeding 24 hours, the maximum permissible concentration of NO2 in the inhaled mixture should be considered as 2 ppm. If the duration of NO inhalation exceeds 24 hours, the permissible concentration of NO2 in the inhaled gas mixture should be limited to 1 ppm.

Еще

Newborn, Nitric Oxide, Nitrogen Dioxide, Pulmonary Hypertension

Короткий адрес: https://sciup.org/142244000

IDR: 142244000   |   DOI: 10.21688/1681-3472-2025-1-61-74

Статья научная